A Transmembrane Accessory Subunit that Modulates Kainate-Type Glutamate Receptors  by Zhang, Wei et al.
Neuron
Article
A Transmembrane Accessory Subunit
that Modulates Kainate-Type Glutamate Receptors
Wei Zhang,2,5 Fannie St-Gelais,1,3,5 Chad P. Grabner,1,3,5 Jonathan C. Trinidad,4 Akio Sumioka,1,3
Megumi Morimoto-Tomita,1,3 Kwang S. Kim,1,3 Christoph Straub,1,3 Alma L. Burlingame,4 James R. Howe,2
and Susumu Tomita1,3,*
1Department of Cellular and Molecular Physiology
2Department of Pharmacology
3Program in Cellular Neuroscience, Neurodegeneration and Repair
Yale University School of Medicine, New Haven, CT 06520, USA
4Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA 94143, USA




Glutamate receptors play major roles in excitatory
transmission in the vertebrate brain. Among iono-
tropic glutamate receptors (AMPA, kainate, NMDA),
AMPA receptors mediate fast synaptic transmission
and require TARP auxiliary subunits. NMDA recep-
tors and kainate receptors play roles in synaptic
transmission, but it remains uncertain whether these
ionotropic glutamate receptors also have essential
subunits. Using a proteomic screen, we have identi-
fiedNETO2, abrain-specificproteinof unknown func-
tion, as an interactor with kainate-type glutamate
receptors. NETO2 modulates the channel properties
of recombinant and native kainate receptors without
affecting trafficking of the receptors and also modu-
lates kainate-receptor-mediated mEPSCs. Further-
more, we found that kainate receptors regulate the
surface expression of NETO2 and that NETO2 protein
levels and surface expression are decreased in mice
lacking the kainate receptor GluR6. The results
show that NETO2 is a kainate receptor subunit with
significant effects on glutamate signaling mecha-
nisms in brain.
INTRODUCTION
Excitatory synaptic transmission in brain is primarily mediated by
the neurotransmitter glutamate. Glutamate released frompresyn-
aptic terminals binds to three classes of ionotropic glutamate
receptors, which are pharmacologically classified as AMPA-
(amino-3-hydroxy-5-methylisoxazole-4-propionic acid), NMDA-
(N-methyl-D-aspartic acid), and kainate-sensitive glutamate
receptors (Dingledine et al., 1999; Hollmann and Heinemann,
1994; Seeburg, 1993). AMPA receptors mediate fast synaptic
transmission, whereas NMDA receptors are involved in synaptic
plasticity. Kainate receptors play multiple roles in synaptic trans-
mission. Postsynaptic kainate receptors mediate slow EPSCs
(Castillo et al., 1997; Kidd and Isaac, 1999; Vignes and Colling-
ridge, 1997), and presynaptic kainate receptors modulate the
release of the excitatory and inhibitory neurotransmitters gluta-
mateandGABA (Chittajalluet al., 1996;Clarkeet al., 1997;Kamiya
and Ozawa, 1998; Rodriguez-Moreno et al., 1997). Furthermore,
presynaptic kainate receptors are involved in long-term potentia-
tion at mossy fiber-CA3 pyramidal cells in hippocampus (Borto-
lotto et al., 1999; Contractor et al., 2001; Schmitz et al., 2001).
Although mice in which kainate receptor expression is genet-
ically disrupted show no kainate receptor activity, overexpres-
sion of kainate receptors does not enhance kainate-receptor-
mediated excitatory postsynaptic current (EPSC), suggesting
that native kainate receptors may contain additional modulatory
proteins. For example, faithful reconstitution of native AMPA
receptor properties in heterologous cells requires coexpression
of transmembrane AMPA receptor auxiliary subunits (TARPs)
(Nicoll et al., 2006). Several cytoplasmic proteins (SAP90/
PSD95, the cadherin/catenin complex, KRIP6, Actinfillin,
PICK1, Syntenin, GRIP) have been identified as kainate receptor
interactors (Coussen et al., 2002; Garcia et al., 1998; Hirbec
et al., 2003; Laezza et al., 2007; Salinas et al., 2006). The primary
effect of these proteins is to modulate receptor localization. Gar-
cia et al. (1998) showed with whole-cell recording that SAP90/
PSD95 causes incomplete receptor desensitization in heterolo-
gous cells. However, subsequent studies at greater time resolu-
tions using outside-out patch membranes showed that SAP90/
PSD95 does not modulate the rate at which receptors desensi-
tize, but rather accelerates recovery from desensitization (Bowie
et al., 2003). Recently, KRIP6 was also shown to modulate
receptor kinetics. KRIP6 enhanced the ratio of steady-state to
peak currents, but did not significantly alter decay kinetics in
heterologous cells (Laezza et al., 2007). Importantly, enhance-
ment of kainate-receptor-mediated EPSCs by overexpression
of these interactors has not yet been shown.
In this study, we identified a brain-specific transmembrane
protein of unknown function, NETO2, using a proteomic screen.
NETO2 slows the decay kinetics of kainate receptors in heterol-
ogous cells without affecting receptor expression at the cell
surface. Single-channel analysis showed that NETO2 also
increases the open probability (Popen) of kainate-receptor chan-
nels, resulting in significantly larger peak glutamate-evoked
currents. NETO2 modulated the agonist sensitivity of kainate
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receptors in heterologous cells and neurons. Importantly,
NETO2 slowed the decay of kainate-receptor-mediated EPSCs,
demonstrating that it directly influences synaptic transmission.
The total amount of NETO2 is decreased in mice lacking the kai-
nate receptor subunit GluR6, and kainate receptors increase the
surface expression of NETO2 in both heterologous cells and
neurons. The results indicate that NETO2 is an accessory
subunit of neuronal kainate receptors that has important effects
on receptor function.
RESULTS
Identification of NETO2 as a Kainate Receptor
Binding Protein
The kainate receptor subunit GluR6 plays major roles in kainate
receptor function (Mulle et al., 1998) and is highly expressed in
cerebellum (Bahn et al., 1994; Smith et al., 1999). To identify
proteins that interact with kainate receptors, we used rat cere-
bella for coimmunoprecipitation experiments with anti GluR6/7
antibody, followed by silver staining.Mass spectrometry analysis
of bands immunoprecipitated with anti GluR6/7 antibody identi-
fied a rat ortholog of NETO2/Btcl2 (99% shared identity of amino
acids), a brain-specific mouse protein of unknown function
(Michishita et al., 2004; Stohr et al., 2002), as well as AKAP8,
the kainate receptor subunits GluR6 and GluR7, and a major
contaminant, keratin (Figure 1A and Table S1 available online).
Figure 1. Native Kainate Receptor Com-
plexes in Brain Contain NETO2
(A) Immunoprecipitation of GluR6/7 from rat cere-
bella membranes showed five specific bands
(asterisks andarrows).Mass spectrometrydemon-
strated that these bands contained NETO2,
AKAP8, and the kainate receptor subunits GluR6
and GluR7 (KARs). No protein was identified from
two bands (asterisks: 130, 150 kDa). Keratin was
identified from all five bands.
(B) Coimmunoprecipitation from rat cerebella
membranes showed that NETO2 interacts with
kainate, but not NMDA and AMPA, receptors.
(C) NETO2, GluR6/7, and KA2 are cofractionated
and highly enriched in the postsynaptic density
(PSD) fraction together with NMDA receptor
subunit NR1 and PSD95, whereas synaptophysin
(Syph) is not.
(D) In rat cerebellum, NETO2 is sensitive to both
PNGaseF and EndoH (similar to NR1).
(E) Domain organization of kainate receptor with
NETO2 and AMPA receptor with transmembrane
AMPA receptor regulatory proteins (TARPs).
NETO2 and GluR6/7 were also coimmu-
noprecipitated with an anti GluR5 anti-
body that also recognizes GluR6 directly
(Figure S1A available online), whereas
AKAP8 was not detected (Figure S1B),
suggesting that the anti GluR6/7 antibody
may directly recognize AKAP8. To test
this possibility, we usedCos-7 cells trans-
fected with FLAG-AKAP8 for immunoprecipitation experiments
with anti GluR6/7 antibody. We found that AKAP8 was weakly
immunoprecipitated with anti GluR6/7 antibody in the absence
of GluR6/7 expression (Figure S1C). We therefore concluded
that NETO2, but not AKAP8, is a kainate receptor interactor.
To determine if NETO2 interacted specifically with kainate
receptors, we generated antibodies against the cytoplasmic
domain of NETO2. NETO2 is a 525 amino acid protein that
contains a signal peptide, and the expected molecular weight
of NETO2 protein after cleavage of the signal peptide is 56 kDa.
Anti NETO2 antibody recognized 58–60 kDa bands in NETO2
transfected CHO cells, but not untransfected cells, and similar
bandswere recognized in lysates from rat brain andmouse cere-
bellar granule cell cultures (Figure S2). Thus, we concluded that
the anti NETO2 antibody recognized NETO2 in brain and trans-
fected cells.We used anti NETO2antibody for coimmunoprecipi-
tation experiments on rat cerebellar lysates. We found that
NETO2 interacts specifically with kainate receptors, but not
with AMPA and NMDA receptors (Figure 1B). In contrast, TARPs
interact specifically with AMPA receptors, but not with kainate
and NMDA receptors (Figure 1B). NETO2 codistributed with the
kainate receptor subunits GluR6/7 and KA2, and was highly en-
riched in the postsynaptic density (PSD) fraction, along with
PSD95 and the NMDA receptor subunit NR1 (Figure 1C).
Sequence analysis indicates that NETO2 contains one trans-
membrane domain, as well as two CUB domains and one
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LDLa domain that are extracellular. Like the NMDA receptor
subunit NR1, NETO2 contains EndoH sensitive sugars (2–3 kDa),
consistent with the idea that NETO2 is a transmembrane protein
(Figure 1D). The predicted structure of NETO2 is substantially
different from that of the TARP family of AMPA receptor auxiliary
subunits (Figure 1E). Here NETO2 is identified as a CUB-domain-
containing protein that binds to ion channels in the vertebrate.
In Caenorhabditis elegans, CUB-domain-containing proteins
LEV-10 and SOL-1 were identified as modulators of acetylcho-
line receptors and GLR-1 AMPA receptors (Gally et al., 2004;
Zheng et al., 2004, 2006). Interestingly, the domain structure of
NETO2 is more similar to the domain structure of invertebrate
proteins that modulate acetylcholine receptors (LEV-10) than
SOL-1, which modulates GLR-1 AMPA receptors (Figure S3).
In addition, NETO2 is similar to the hypothetical proteins
Q9XUU2 in C. elegans and Q9VYC7 in Drosophila melanogaster
(Figure S3 and Discussion).
NETO2 Modulates the Functional Properties, but Not
Surface Trafficking, of Kainate Receptors
To begin to explore the functional role of NETO2 interactions with
kainate receptors, we coexpressed these proteins in Xenopus
laevis oocytes, in which protein expression could be more tightly
regulated by complementary RNA (cRNA) injection (in compar-
ison with transfection of cDNAs in mammalian cells). The detec-
tion of glutamate-evoked currents in oocytes injected with 0.5 ng
GluR6 cRNA by two-electrode voltage-clamp recording (TEVC)
required reduction of desensitization with concanavalin A
(Wong and Mayer, 1993). In contrast, large glutamate-evoked
currents were routinely recorded without concanavalin A treat-
ment in oocytes coinjected with 0.5 ng NETO2 cRNA and 0.5 ng
GluR6 cRNA, whereas coexpression of NETO2 had no effect on
Figure 2. NETO2 Modulates Channel Prop-
erties, but Not Surface Trafficking, of Kai-
nate Receptors
Oocytes were injected with cRNAs encoding
GluR6 (0.5 ng), GluR1 (1 ng, 0.1 ng) or GluR1
(0.1 ng) and stargazin (STG; 0.5 ng) with or without
NETO2 (0.5 ng), and responses to 10 mM gluta-
mate were measured with TEVC. (A and B)
NETO2 enhances maximal glutamate-evoked
currents (IMax) for GluR6, but not GluR1, channels
(n = 8–10) (B). (C) Addition of NETO2 cRNA
enhances currents in oocytes coinjected with
HA-GluR6 cRNA (0.5 ng), but not surface expres-
sion of HA-GluR6 (0.5 ng). Data are shown as
mean ± SEM. n = 10–11. ***p < 0.005.
the activity of AMPA receptors or
stargazin-like TARP/AMPA receptor
complexes expressed at the minimum
levels to detect further enhancement
(Figures 2A, 2B, and S4). To determine
whether the NETO2-associated increase
in GluR6 currents was due to an increase
in receptor expression at the cell surface,
we measured in parallel glutamate-
evoked currents by TEVC and the surface expression of kainate
receptors by chemiluminescence. Oocytes were injected with
extracellular HA-epitope-tagged GluR6 at nonsaturating
amounts (0.5 ng) of HA-GluR6 cRNA (Figure S5) with varying
amounts of NETO2 cRNA (Tomita et al., 2005). We found that
NETO2 enhanced maximal glutamate-evoked currents in
a dose-dependent manner, but had no effect on surface expres-
sion (Figure 2C and the raw data in Figure S6), suggesting that
NETO2 enhances GluR6 currents by modulating the functional
properties of the receptors, perhaps by slowing desensitization.
NETO2 Modulates Decay Kinetics and Peak Open
Probability of Kainate Receptors
To examine NETO2modulation of receptor properties at a better
time resolution, we expressed NETO2 and GluR6 in tsA201 cells
and applied glutamate to outside-out patches from the trans-
fected cells with a fast piezoelectric system. Coexpression of
GluR6 and NETO2 at a cDNA ratio of 1:10 resulted in significant
slowing of both desensitization and deactivation (Figures
3A–3C). Relative to the corresponding values for GluR6 alone,
the NETO2-associated increase in mean weighted tau values
was 500% for desensitization and 64% for deactivation. The
results obtained with cDNA ratios of 1:10 and 1:30 were similar,
indicating that most GluR6 receptors in the patches studied con-
tained NETO2. In addition, NETO2 did not modulate desensitiza-
tion of GluR1 AMPA receptors (time constant of desensitization:
GluR1 alone, 2.4 ± 0.2 ms, n = 5; GluR1 + NETO2, 2.2 ± 0.5 ms,
n = 4). Two-pulse protocols showed that NETO2 also causes
GluR6 receptors to recover faster from desensitization, espe-
cially at short interpulse intervals (Figure 3D). Together, the
slower entry into desensitization and faster recovery seen with
NETO2 coexpression resulted in a 9-fold enhancement of
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Figure 3. NETO2 Modulates Kainate Receptor Kinetics and Peak Open Probability
(A and B) Responses to 10mMglutamate in outside-out patches from tsA201 cells transfected with GluR6 alone or GluR6 and NETO2. Glutamate was applied for
200 ms (A) or 1 ms (B). The time constants (relative amplitude) are from monoexponential or biexponential fits to the decays of the currents.
(C) The fits were used to calculate weighted time constants of desensitization and deactivation. NETO2 coexpression slowed both desensitization and deacti-
vation significantly (n = 6–9).
(D) Recovery from desensitization for GluR6 alone (n = 5) andGluR6 andNETO2 (n = 6). NETO2markedly sped recovery at short intervals, but did not alter the slow
component of recovery.
(E) Examples of single-channel currents evoked by 10 mM glutamate in patches containing four GluR6 (left) or three GluR6+NETO2 channels (right). NETO2
increased the probability of channel opening and the duration of channel activity.
(F) Burst-length distributions from the patches in (E). The similar fast component present in all such distributions is off-scale. NETO2 coexpression produced
approximately a 2-fold increase in the time constant of the slow component.
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steady-state currents (0.11 ± 0.02% versus 1.01% ± 0.24% of
the peak current, n = 6 and 9, respectively). Notably, the differ-
ence in kinetics suggests that there is no endogenous NETO2
in tsA201 cells, because human and rat NETO2 should have
similar effects on receptor kinetics given the high degree of iden-
tity (97%) the two proteins share.
To determine the effect of NETO2 on unitary receptor proper-
ties, we made concentration jumps on patches containing only
a few channels (Figure 3E). As reported before (Swanson et al.,
1996), GluR6-Q channels displayed three open levels with
conductances of approximately 7, 17, and 26 pS. NETO2 coex-
pression had no effect on unitary conductance and did not alter
the relative frequency or the mean duration of openings to each
conductance level (Table 1). However, the duration of bursts of
openings (tcrit = 4 ms) was clearly longer with NETO2 (Figures
3E and 3F) and the mean duration of these bursts was increased
significantly (Table 1).
It was evident from inspection of the records that NETO2
coexpression dramatically increased channel activity. In patches
in which the maximum number of receptors that open simulta-
neously was estimated to be three or four, the number of jumps
that produced no detectable openings (‘‘failures’’) was much
higher in the absence of NETO2 coexpression (Figure 3E). Our
measurements of the relative frequency of openings to each
conductance level with and without NETO2 (Table 1) were
used to calculate the mean single-channel current, which
together with the number of active receptors in the patch allowed
us to estimate the Popen at the peak of the ensemble current
(peak Popen). NETO2 coexpression increased peak Popen
significantly (Figure 3G). In total, the results show that the inclu-
sion of NETO2 in kainate receptor assemblies modulates both
the amplitude and kinetics of ensemble currents evoked by rapid
pulses of glutamate, leading to a marked increase in charge
transfer. Our results suggest that the mechanism underlying
NETO2-mediated kainate receptor modulation differs from
TARP modulation of AMPA receptors. TARPs slow both the
deactivation and desensitization of AMPA receptors to similar
extents, suggesting that they decrease the activation energy
for channel opening, whereas NETO2 has larger effects on
desensitization and may primarily alter the rate constants gov-
erning transits in and out of desensitized states (Figure 3H).
NETO2Modulates Kainate-Receptor-MediatedmEPSCs
We next examined whether NETO2 modulates the properties of
the synaptic receptors that mediate kainate-receptor miniature
EPSCs (mEPSCs). We used cerebellar granule cells for these
studies because their small size allowed us to measure EPSC
kinetics accurately. Tominimize the contribution of AMPA recep-
tors, we used neurons from stargazer mice, which lack AMPA-
receptor-mediated EPSCs (Chen et al., 2000; Hashimoto et al.,
1999). As published previously (Chen et al., 2000; Cho et al.,
2007; Milstein et al., 2007), we observed AMPA-receptor-medi-
atedmEPSCs in cerebellar granule cells fromwild-typemice, but
not in cells from stargazer mice (data not shown). NMDA recep-
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blocked by the inclusion of AP-5, picrotoxin, and tetrodotoxin
(respectively) in the external solution.
We did not detect mEPSCs in stargazer granule cells, even
after transfecting the neurons with GluR6, although we routinely
detected AMPA receptor mEPSCs in neurons in parallel cultures
transfected with stargazin. We hypothesized that the low peak
Popen of GluR6 channels limited our detection of kainate recep-
tors at synapses. We therefore transfected granule cells with
a GluR6 mutant in which substitution of lysine for arginine at
position 696 reduces receptor desensitization (Priel et al.,
2006). In oocytes injected with cRNAs, NETO2 enhanced gluta-
mate-evoked currents of GluR6 (K696R) receptors without
altering surface expression of the receptors (Figure S7). We did
observe mEPSCs in some neurons transfected with GluR6
(K696R) alone, although the frequency of the events was very
low (Figure 4A). In contrast, mEPSCs were observed in most
neurons cotransfected with NETO2 and GluR6 (K696R), and
the frequency of these events was significantly greater (Fig-
ure 4A). Examples of representative mEPSCs are shown in
Figures 4B and 4C. The mEPSCs detected in each type of trans-
fected neuronweremediated by kainate receptors, as confirmed
by their resistance to block by selective AMPA receptor antago-
nists (50 mMGYKI 53655 and 100 mMSYM2206) (Figures 4B and
4C). The decay kinetics of the kainate-receptor-mediated
mEPSCs with and without NETO2 coexpression were different
and were slower in neurons cotransfected with NETO2 (Fig-
ure 4D), and NETO2 significantly increased the half-width of indi-
vidual mEPSCs, as well as the decay time and charge transfer of
ensemble averages from individual neurons (Figure 4E). Addi-
tionally, in cerebellar granule cells from stargazer mice, NETO2
slowed the decay of spontaneous kainate-receptor EPSCs in
neurons transfected with GluR5. The time constants obtained
from fitting average EPSCs were 0.87 ± 0.10 ms for neurons
transfected with GluR5 alone and 2.6 ± 0.36 ms for neurons
Table 1. Effect of NETO2 on the Unitary Properties of GluR6-Q
Channels
GluR6-Q GluR6-Q + NETO2
Conductance (pS) O1 7.4 ± 0.3 (24.7%) 7.4 ± 0.2 (18.2%)
O2 16.9 ± 0.4 (43.2%) 16.4 ± 0.5 (51.3%)
O3 27.0 ± 0.8 (32.1%) 25.5 ± 0.6 (30.5%)
Open time (ms) O1 0.87 ± 0.13 0.70 ± 0.05
O2 0.60 ± 0.09 0.80 ± 0.07
O3 0.81 ± 0.14 0.89 ± 0.07
Burst length (ms) 0.64 ± 0.08 0.66 ± 0.10
4.60 ± 0.38 7.45 ± 0.82*
Mean ± SEM values from four or five patches are listed. Conductance
levels and open times for each level were estimated with QuB software.
Bursts were defined as a series of openings (to any level) that were sepa-
rated by shuttings briefer than 4 ms. The distributions of burst durations
were fitted with two exponential components. The fast component was
similar in all distributions examined. *p < 0.05.(G) Mean values for peak Popen obtained from patches containing GluR6 and GluR6+NETO2 channels (n = 6).
(H) Mean percentage increases in the weighted time constants of deactivation and desensitization, as well as peak Popen, produced by stargazin coexpression
with GluR1 (9) and NETO2 coexpression with GluR6. Data are given as mean ± SEM. *p < 0.05, **p < 0.01.
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mEPSCs were recorded from stargazer cerebellar granule cells transfected with GluR6 (K696R) alone (69 events from 14 neurons) or GluR6 (K696R) and NETO2
(233 events from 17 neurons).
(A) NETO2 coexpression significantly increased the frequency of kainate receptor mEPSCs. ***p = 0.01.
(B and C) Representative mEPSCs (eight traces on left) and ensemble averages (right) from neurons transfected with GluR6 (K696R) alone (B) or with GluR6
(K696R) and NETO2 (C). Addition of the AMPA receptor antagonists GYKI 53655 (50 mM) and SYM 2206 (100 mM) did not alter mEPSC kinetics.
(D) Ensemble mEPSCs from neurons transfected with GluR6 (K696R) with or without NETO2 in the presence of the AMPA receptor antagonists GYKI 53655
(50 mM) and SYM 2206 (100 mM). NETO2 slows the decay kinetics of mEPSCs.
(E) Kinetic parameters (half-width, decay time, and charge transfer) calculated from mEPSCs from neurons transfected with GluR6 (K696R) alone or with GluR6
(K696R) and NETO2.
Data are given as mean ± SEM. *p < 0.05.cotransfected with GluR5 and NETO2 (p < 0.05). The results
indicate that NETO2 can modulate kainate-receptor-mediated
synaptic transmission.
NETO2 Modulates the Agonist Sensitivity
of Kainate Receptors
It is well known that kainate-receptor-mediated EPSCs are less
than 10% of the amplitude of AMPA-receptor-mediated EPSCs
(Castillo et al., 1997; Kidd and Isaac, 1999; Vignes and Colling-
ridge, 1997), and in cerebellar granule cells whole-cell kainate
receptor currents are on average smaller than 20 pA even
when desensitization is reduced with concanavalin A (Pember-
ton et al., 1998; Smith et al., 1999). Because we were unable to
routinely detect native kainate receptor mEPSCs in granule
cells (or hippocampal neurons), we used a pharmacological390 Neuron 61, 385–396, February 12, 2009 ª2009 Elsevier Inc.approach to determine whether endogenous kainate receptors
contain NETO2. For AMPA receptors, modulation of receptor
kinetics by TARP auxiliary subunits is associated with changes
in the relative efficacy of glutamate and kainate (Tomita et al.,
2005). To determine whether NETO2 changed the pharma-
cology of kainate receptors, we compared glutamate- and kai-
nate-evoked currents in oocytes injected with GluR6 or GluR6
coexpressed with NETO2. To reduce desensitization, the
oocytes were pre-exposed to concanavalin A (Wong and
Mayer, 1993). We found that the ratio of kainate- and gluta-
mate-evoked currents is increased by coexpression of
NETO2 (Figure 5A) without marked changes in agonist potency
(Figure S8).
To test whether NETO2 is incorporated in functional neuronal
receptors, we therefore used whole-cell current measurements
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glutamate efficacy. We first generated several NETO2 shRNA
constructs and transfected NETO2 shRNA plasmids with
NETO2 cDNA in CHO cells to detect NETO2 expression. One
NETO2 shRNA construct effectively suppressed NETO2 expres-
sion, and this suppression could be rescued by coexpression of
a NETO2mutant carrying silent mutations (Rescue) in the shRNA
target sequence (Figure 5B). Because we could verify the spec-
ificity of the shRNA with the Rescue construct, we transfected
the NETO2 shRNA plasmid alone or with the NETO2 silent
Figure 5. NETO2 Modulates the Agonist Sensitivity of Kainate
Receptors
(A) Oocytes injected with NETO2 (0.5 ng) and GluR6 (0.1 ng) cRNAs were pre-
exposed to concanavalin A and currents evoked by glutamate (500 mM; IGlu) or
kainate (20 mM; IKA) were measured with TEVC (n = 7–8). Coinjection of NETO2
increases the relative efficacy of kainate.
(B) CHO cells were cotransfected with expression vectors for wild-type (wt) or
mutant (mut) NETO2 and NETO2 shRNA vector. NETO2 shRNAs eliminated
detectable protein for NETO2wild-type (wt) without affecting actin expression.
The knockdown was prevented by silent point mutations in the NETO2 cDNA
(NETO2.mut). shRNA parent vector (Control.shRNA) had no effect.
(C) Inward whole-cell currents evoked in cultured hippocampal neurons
(80 mV) by the successive application of 500 mM glutamate and 20 mM kai-
nate. The neurons (DIV 10–11) were transfected at DIV 7. Agonists were
applied by local superfusion with a large-bore glass pipette. Solution
exchange times were about 1 s. Neurons were pre-exposed to concanavalin
A to reduce kainate receptor desensitization and all solutions contained
SYM 2206 (100 mM), AP-5 (50 mM), and tetrodotoxin (2 mM) to block AMPA
receptors, NMDA receptors, and sodium channels, respectively.
(D) Currents evoked by glutamate (500 mM; IGlu) or kainate (20 mM; IKA) in hippo-
campal cultured neurons transfected as indicated. NETO2.shRNA decreased
the ratio of kainate- and glutamate-evoked currents (n = 8). Coexpression of
NETO2.mut rescued this suppression (n = 6). Data are given as mean ±
SEM. ***p < 0.005.mutant in primary hippocampal cultures and measured kainate
and glutamate-evoked steady-state currents by whole-cell
recording after pre-exposing the cultures to concanavalin A.
The vector used (pLLox3.7) directs the expression of both
shRNA and GFP, allowing identification of neurons expressing
the shRNA. The parent vector alone served as a control. Expres-
sion of NETO2 shRNA selectively decreased the ratio of kainate-
and glutamate-evoked steady-state currents in hippocampal
neurons (Figures 5C and 5D), strongly indicating that NETO2
interacts with native kainate receptors.
Kainate Receptors Modulate Cell Surface Expression
of NETO2 in Heterologous Cells and Neurons
Although NETO2 did not modulate the surface expression of kai-
nate receptors (Figure 2C), both kainate receptors and NETO2
are transmembrane proteins and likely interact in the endo-
plasmic reticulum (ER). We therefore wondered whether kainate
receptors modulate NETO2 trafficking. To examine this possi-
bility, we used chemiluminescence (quantified with a Luminome-
ter) to measure surface expression of NETO2 in oocytes injected
with extracellular HA-epitope-tagged NETO2 and varying
amounts of GluR6 (Tomita et al., 2005). We found that GluR6
enhances the surface expression of NETO2 in a GluR6-dose-
dependent manner (Figure 6A and raw data in Figure S9).
Mice lacking two different TARPs known to modulate AMPA
receptor trafficking, stargazin and g-8, have been reported to
show a decreased total amount of AMPA receptors (Fukaya
et al., 2006; Rouach et al., 2005; Tomita et al., 2003). Because
GluR6 modulates NETO2 trafficking (Figure 6A), we asked
whether the total amount of NETO2 is decreased in mice lacking
GluR6. To test this, wemeasuredNETO2 expression in heterozy-
gous and homozygous littermates of GluR6 knockout mice
(Mulle et al., 1998). We found that the total amount of NETO2
in the cerebella of GluR6 homozygous mice was reduced by
60% relative to a GluR6 heterozygous littermate, whereas the
total amounts of TARP isoforms and the NMDA receptor subunit
NR1 were unaltered (Figures 6B and 6C). The reduced NETO2
expression was not due to a decrease in transcription, since
northern blot analysis of cerebella of GluR6 littermates demon-
strated no alteration in NETO2 mRNA levels (Figures 6D and 6E).
To determine the extent to which GluR6 expression influences
NETO2 trafficking in neurons, we used cell-impermeable NHS-
SS-biotin tomeasure the surface expression of NETO2 in primary
cerebellar granule cells from GluR6 heterozygous and homozy-
gous littermates (Tomita et al., 2004). Because the total amount
of NETO2 is decreased in GluR6 knockout mice (Figures 6B
and 6C), we adjusted the protein loaded (2-fold) so that the total
amount of NETO2 was similar in the two groups (Figure 6F). We
found that surface expression of NETO2 in cultures from GluR6
homozygous mice was reduced 70% relative to cultures from
GluR6 heterozygous littermates, whereas the surface expression
of NR1 was unaltered (Figures 6F and 6G).
DISCUSSION
Here we identified a transmembrane protein, NETO2, which
modulates kainate receptor function in brain. In summary,
three main findings support the conclusion that NETO2 is aNeuron 61, 385–396, February 12, 2009 ª2009 Elsevier Inc. 391
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tors. First, NETO2 copurifies with kainate receptors from
mammalian brain. Second, NETO2 modulates the kinetics, as
well as the agonist sensitivity, of kainate receptors in both heter-
ologous cells and neurons. Third, NETO2 trafficking in heterolo-
gous cells and neurons is modulated by kainate receptors.
Sequence alignment shows that rat NETO2 shares high
sequence identity (56%) with NETO1 (Figure S3). Therefore, we
also examined whether NETO1 modulated kainate receptor
function. We found that NETO1 enhanced glutamate-evoked
current from GluR6 (Figure S10); thus, we defined NETO1 and
NETO2 as a family of kainate receptor regulatory proteins
(KARPs). Although NETO1 and NETO2 are CUB-domain-con-
taining transmembrane proteins that interact with ion channels
in vertebrates, two other CUB-domain-containing proteins in
C. elegans, SOL-1 and LEV-10, were previously identified as
ion channel modulators of GLR-1 AMPA receptors and acetyl-
choline receptors, respectively (Gally et al., 2004; Zheng et al.,
2004, 2006). Interestingly, the acetylcholine receptor modulator
LEV-10 shares a similar domain structure with NETO2, as well
as with the AMPA receptor subunit SOL-1. In addition, the
domain structure of NETO2 is similar to the hypothetical proteins
Q9XUU2 in C. elegans and Q9VYC7 in D. melanogaster.
Our identification of a CUB-domain-containing protein as
an ion channel accessory subunit in vertebrates supports
a conserved role for CUB-domain-containing proteins as ion
channel subunits through evolution, and some of the 47 CUB-
domain-containing proteins encoded in the human genome
may play roles in ion channel modulation (Venter et al., 2001).
In the invertebrate, three proteins, SOL-1, GLR-1, and the auxil-
iary subunit STG-1, form functional AMPA receptor complexes
(Walker et al., 2006a). However, we find that NETO2 does not
form protein complexes with AMPA receptors and their auxiliary
subunit, stargazin-like TARP (STG-1 vertebrate homolog)
(Figure 1B). SOL-1 slows desensitization of GLR-1 AMPA recep-
tors without effects on receptor trafficking (Walker et al., 2006b),
which is similar to the effects of NETO2 on kainate receptors;
however, there is a distinct difference in the domain structure
of NETO2 and SOL-1. NETO2 contains one LDLa domain in its
extracellular domain, whereas SOL-1 does not. Therefore, we
examined the role of the LDLa domain of NETO2 in modulating
kainate receptor activity. Since cysteine residues in the LDLa
domain play critical roles in its function, we generated
a NETO2mutant in which we substituted serines for two cysteine
residues in the LDLa domain and coexpressed the mutant
NETO2 with GluR6 in oocytes. The mutant NETO2 successfully
expressed at the cell surface (Figure S11). Comparison of gluta-
mate-evoked currents with andwithout expression of themutant
NETO2 indicated that the LDLa domain is necessary for modula-
tion of kainate receptor activity (Figure S11). This result indicates
that NETO2 andSOL-1 function distinctly and that theremight be
NETO2 homologs in the invertebrate kainate receptor complex
and SOL-1 homologs in the vertebrate AMPA receptor complex.
Coexpression of NETO2 with GluR6 produced marked effects
on both the peak amplitude and the kinetics of glutamate-
evoked currents. Although other kainate-receptor interactors
have been shown to increase steady-state currents and speed
recovery from desensitization (Garcia et al., 1998; Laezza
Figure 6. Kainate Receptors Modulate Cell
Surface Expression of NETO2
(A) Oocytes were injected with HA-NETO2 (20 pg)
and various amounts of GluR6 cRNA as indicated,
and surface expression of NETO2 was quantified
by chemiluminescence (n = 8). GluR6 specifically
and dose-dependently increased the surface
expression of NETO2, whereas GluR1 or GluR1
with stargazin (STG) did not.
(B–E) Quantitative analysis of protein expression
(B and C) and mRNA levels (D and E) in GluR6
heterozygous (+/) and homozygous (/) litter-
mate mice. (B and C) NETO2 expression was
reduced in GluR6/ mice, whereas expression
of the NMDA receptor subunit NR1 and TARP
was unaffected (n = 4). Arrow and asterisk indicate
NETO2 and nonspecific band, respectively. Data
are given as mean ± SEM. ***p < 0.005. (D and E)
mRNA level of NETO2 and NR1 was unaffected
in GluR6/ mice (n = 3).
(F and G) Cerebellar cultures from GluR6 litter-
mates were biotinylated, solubilized, and precipi-
tated with neutravidin-beads. Twice as much total
protein was loaded for the sample from GluR6
homozygous mice to account for the reduced
NETO2 expression in these cultures relative to
cultures from heterozygous littermates. The
surface expression of NETO2 is dramatically
decreased in GluR6 homozygous cultures,
whereas NMDA receptor subunit NR1 is unaltered
(n = 3). Data are given as mean ± SEM. **p < 0.01.392 Neuron 61, 385–396, February 12, 2009 ª2009 Elsevier Inc.
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that alters the decay kinetics of currents evoked by rapid pulses
of glutamate. Our single-channel data also indicate that, in the
absence of NETO2, the vast majority of GluR6 receptors desen-
sitize without opening when they are rapidly exposed to gluta-
mate, a conclusion which differs from previous estimates of
peak Popen values for GluR6 from nonstationary noise analysis
(Traynelis andWahl, 1997). The association of NETO2with native
kainate receptors would therefore be expected tomodulate both
the amplitude and the decay of kainate-receptor-mediated
currents.
Indeed, coexpression of NETO2 increased significantly both
the frequency and decay time of kainate-receptor-mediated
mEPSCs. The increased frequency of mEPSCs in NETO2-trans-
fected neurons likely reflects the ability of NETO2 to increase
peak Popen and therefore the peak amplitude of kainate-
receptor mEPSCs. Even with NETO2 coexpression the ampli-
tude of the mEPSCs was near the limit of detection, and it is
probable that many events were too small to detect in the
absence of NETO2. The effect of NETO2 in slowing the decay
of mEPSCs was also significant, and the extent of the slowing
was consistent with the effect of NETO2 on the deactivation
time course of recombinant GluR6 receptors.
NETO2/Btcl2 mRNA is abundant in the cerebellar granule cell
layer and hippocampus CA3 region (Michishita et al., 2004) (also
see websites of Allen Brain Atlas, http://www.brain-map.org/,
and Brain Gene Expression Map, http://www.stjudebgem.org/
web/view/probe/viewProbeDetails.php?id=10). Interestingly,
these neurons are strongly labeled with [3H]-kainate in the rat
brain (Foster et al., 1981; Monaghan and Cotman, 1982). In
most neurons, kainate receptor EPSCs decay with time
constants of 50–200 ms (Bannister et al., 2005; Castillo et al.,
1997; Kidd and Isaac, 1999; Vignes and Collingridge, 1997),
whereas CA1 interneurons in hippocampus show briefer time
constants of 10 to 15 ms (Cossart et al., 1998; Frerking et al.,
1998), which are closer to the time constants of deactivation
(2–5 ms) and desensitization (5–10 ms) for recombinant kainate
receptors (Dingledine et al., 1999; Erreger et al., 2004). Interest-
ingly, in situ hybridization showed that NETO2/Btcl2 is not ex-
pressed in CA1 interneurons (Michishita et al., 2004), although
CA1 interneurons do express NETO1. Our results showed that
NETO1 modulates kainate receptor activity, but not as much
as NETO2 does, which might in part explain the faster decay
kinetics of kainate-receptor-mediated EPSCs in CA1 interneu-
rons than that in CA3 pyramidal cells. While the effect of
NETO2 on the kinetics of native kainate receptors is at this point
unknown, the inclusion of NETO2 in native kainate receptorsmay
contribute to the often noted discrepancy between the decay
time course of kainate receptor synaptic currents and the decay
kinetics of recombinant receptors (Castillo et al., 1997; Dingle-
dine et al., 1999; Erreger et al., 2004; Huettner, 2003; Lerma,
2006; Vignes and Collingridge, 1997).
Our results indicate that NETO2, and the structurally distinct
TARPs, modulate glutamate receptor properties through distinct
mechanisms, with TARPs primarily influencing AMPA receptor
activation and NETO2 primarily altering the rates at which kai-
nate receptors enter and recover from desensitization. Crystal
structures of the ligand binding domain of AMPA receptorsand kainate receptors have been solved (Armstrong and
Gouaux, 2000; Mayer, 2005; Nanao et al., 2005). Upon agonist
binding, the clamshell-like structure of the ligand binding domain
closes and triggers conformational changes that open the
channel pore, which ultimately causes the dimer interface to
rearrange and receptor desensitization (Sun et al., 2002). One
explanation for our findings that NETO2 slows desensitization
is that NETO2 stabilizes the dimer interface.
The AMPA receptor auxiliary subunit, TARP/stargazin, is
required for the surface expression of AMPA receptors in cere-
bellar granule cells (Chen et al., 2000) and modulates receptor
properties (Tomita et al., 2005), suggesting that most AMPA
receptors contain TARP/stargazin (at least in cerebellar granule
cells). However, kainate receptor trafficking does not require
NETO2, but rather, kainate receptors regulate the surface
expression of NETO2. The reduced expression of NETO2 in
cerebella from GluR6 knockout mice may indicate that GluR6
enhances the surface trafficking of NETO2 and that, in the
absence of GluR6, NETO2 accumulates intracellularly and is
degraded. Alternatively, NETO2 may traffic to the cell surface
in neurons lacking GluR6, but it is unstable when not coas-
sembled with GluR6. Similar to NETO2, total protein and surface
expression of KA2 were reduced in hippocampus of GluR6 and
GluR5 knockout mice (Christensen et al., 2004; Nasu-Nishimura
et al., 2006; Ruiz et al., 2005). Experiments with EndoH showed
that the ER retention of KA2 is increased in GluR6 knockout
mice, indicating that KA2 does not traffic by itself (Nasu-Nishi-
mura et al., 2006). Because NETO2 is sensitive to EndoH treat-
ment like NR1 (Figure 1D), it remains unclear whether NETO2
degrades in GluR6 knockout mice at the cell surface or in the ER.
In GluR6 knockout mice, about 30% of total and surface
expression of NETO2 was still detected in cerebellum and cere-
bellar granule cells, respectively. The residual NETO2 might be
trafficked or stabilized by other kainate receptor subunits in
cerebellum, or a small portion of NETO2 could be trafficked
without GluR6. Because GluR6 could traffic to the cell surface
without NETO2, there is also the possibility that two types of kai-
nate receptors may exist in brain, one with and one without
NETO2. Since these two types of kainate receptors display
different channel properties, kainate receptors with and without
NETO2 may play roles in distinct functions or may be targeted to
different subcellular compartments. Further studies on the
mechanisms of kainate receptor trafficking and localization are
required to examine this possibility. Related to this question,
the stoichiometry of NETO2 and kainate receptors is unknown.
Both NETO2 and kainate receptors are transmembrane proteins
(like TARPs and AMPA receptors). It is therefore likely that the
molecular structure of NETO2/kainate receptor complexes at
high resolution will be required to ascertain the stoichiometry
of the two proteins.
EXPERIMENTAL PROCEDURES
Antibodies
The following antibodies were used: rabbit polyclonal antibodies to GluR1,
GluR2/3, GluR4, GluR5, GluR6/7, KA2, and TARP (Millipore); goat polyclonal
antibody to AKAP8 (abcam); and mouse monoclonal antibodies to NR1 and
NR2B (BD Biosciences), PSD95 (ABR), synaptophysin (Sigma), and actin
(Chemicon). Polyclonal antisera to NETO2 proteins were raised by injectingNeuron 61, 385–396, February 12, 2009 ª2009 Elsevier Inc. 393
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NETO2. Antisera were affinity purified on agarose columns containing the His-
NETO2 fusion proteins.
Plasmid Construction
Rat NETO2 cDNA was cloned by RT-PCR and subcloned into pGEMHE and
pCDNA3.1 (Invitrogen). NETO2 shRNA oligonucleotide (AGTGTTGCTAATAAC
GGTA TTCAAGAGA TACCGTTATTAGCAACACT) was inserted into pLLox3.7.
The NETO2 silent mutant carries fivemutations (GGTACTACTGATAACGGTA),
which do not alter amino acids encoded.
Immunoprecipitation
Rat cerebella membranes were suspended in lysis buffer (20 mM Tris-Cl
[pH 8.0], 2mMEDTA, and 1mMDTT), 1%Triton X-100, and protease inhibitors
(1 mM PMSF and 10 mg/ml leupeptin), and were centrifuged at 100,0003 g for
1 hr. Precleared supernatants were then incubated with 3 mg of affinity-purified
antibodies and 20 ml of protein A sepharose beads. Bound proteinswere eluted
by heating the resin in 20 ml of 1XSDS-PAGEsample buffer andwere separated
by SDS-PAGE, which was followed by silver staining.
Mass Spectrometry Analysis
Protein bands were excised from a silver-stained gel and diced. The gel pieces
were reduced with 2.1 mM dithiothreitol, alkylated with 4.2 mM iodoaceta-
mide, and digested for 12 hr with trypsin (12 ng/L) at 37C. Peptides were
separated using a 75 mm 3 15 cm reverse phase C18 column (LC Packings,
Sunnyvale, CA). The LC eluent was coupled to a microionspray source
attached to a QSTAR Pulsar mass spectrometer (Applied Biosystems, Foster
City, CA).
PSD Fraction and Glycosylation Assay
PSD fractionation and glycosylation assay were performed as described
(Tomita et al., 2003).
Electrophysiology Using X. laevis Oocytes
TEVC was performed as described (Tomita et al., 2004). Briefly, GluR6,
NETO2, GluR1, and stargazin constructs were subcloned into pGEMHE vector
and cRNAs were transcribed in vitro using T7 mMessage mMachine (Ambion).
TEVC analysis was performed 4–5 days after injection at room temperature in
recording solution containing (in mM) 100 NaCl, 1.0 KCl, 1.0 MgCl2, 0.5 BaCl2,
and 5 HEPES (pH 7.4). The membrane potential was held at70 mV. Maximal
glutamate-evoked currents were taken as responses to 10 mM glutamate. In
some experiments, steady-state responses to glutamate (Glu: 500 mM) or kai-
nate (KA: 20 mM) were recorded after 5 min incubation with concanavalin A
(10 mg/ml).
Surface Labeling of Oocytes
Surface labeling was performed as described (Tomita et al., 2005; Zerangue
et al., 1999). Briefly, 4–5 days after injection oocytes were incubated for 1 hr
with 0.25 mg ml1 rat anti-HA antibody (3F10, Roche), followed by 30 min
with horseradish-peroxidase-conjugated anti-rat immunoglobulin. Individual
oocytes were then placed into 50 ml of SuperSignal ELISA Femto maximum
sensitivity substrate (Pierce) and quantified by chemiluminescence using a
Veritas Microplate Luminometer (Turner Biosystems).
Primary Neuronal Cultures andBiotinylation of Cell Surface Proteins
Cerebellar granule cell cultures were maintained as described (Cho et al.,
2007). Surface expression of glutamate receptors and NETO2 was quantitated
as described (Tomita et al., 2004). Briefly, cerebellar granule cell cultures at DIV
10 were labeled for 12 min at 4C with 1.5 mg/ml sulfo-NHS-SS-biotin.
Membranes were prepared and the biotinylated proteins were precipitated
with Neutravidin-agarose and detected by western blotting.
Outside-Out Patch Recordings
tsA201 cells were maintained and transfected as previously described (Robert
and Howe, 2003). Individual GluR6 and NETO2 cDNAs were cotransfected at
a 1:3, 1:10, or 1:30 ratio. Individual GluR1 and NETO2 cDNAs were cotrans-
fected at a 1:10 ratio. Recordings from outside-out patches were performed394 Neuron 61, 385–396, February 12, 2009 ª2009 Elsevier Inc.1 to 3 days posttransfection at room temperature with an EPC-9 amplifier
(HEKA) at a holding potential of 100 mV (Robert and Howe, 2003). The
external solution was (in mM) 150 NaCl, 3 KCl, 2 CaCl2, 1 MgCl2, 5 glucose,
and 10 HEPES (pH 7.4). Patch pipettes (open tip resistance, 3–5 MU) were
filled with a solution containing (in mM) 135 CsF, 33 CsOH, 2 MgCl2,
1 CaCl2, 11 EGTA, and 10 HEPES (pH 7.4). The size of the peak currents
was 0.2 to 2 nA (60%–70% series resistance compensation). Glutamate was
added to the external solution and applied with theta glass pipettes mounted
on a piezoelectric bimorph. Agonist-evoked currents were analog low-pass
filtered at 3 kHz, sampled at 20–30 kHz, and analyzed with Igor software
(Tomita et al., 2005). Recovery from desensitization was studied by making
two consecutive 200 ms applications of 1 mM glutamate at different intervals.
The results were fitted with an equation consisting of two Hodgkin-Huxley
components (Zhang et al., 2006).
Single-Channel Data Analysis
Single-channel currents evoked by 10 mM glutamate were analog low-pass
filtered at 5 kHz, sampled at 25 kHz, and written directly to the hard drive of
two computers. One computer stored the records in PULSE format (the soft-
ware used to run the EPC-9) and the other stored the data in QuB (http://
www.qub.buffalo.edu) format (the software used for single-channel analysis).
The patches analyzed gave maximum peak currents of 5 to 15 pA at100 mV
and appeared to contain 3 to 10 active channels. Responses to 200 to 500
concentration jumps (400 ms applications) were obtained from each patch.
After filtering the digitized records at 4 kHz and manually setting the closed-
channel current (r.m.s., 240 to 270 pA) to 0, the entire filtered data set from
a given patch was idealized with the segmental k-means (SKM) algorithm of
QuB to identify single-channel transitions and estimate conductance levels
and event durations (Qin, 2004; Qin et al., 1996). The time resolution was set
to four sample intervals (160 ms, 1.5 filter rise times). Open and shut times
and burst durations were exported to Channelab (Synaptosoft Inc) and histo-
grams (10–12 bins per decade) of the dwell times were displayed and fitted
with log-likelihood log-binned subroutines. All burst distributions contained
a fast component (primarily brief single openings) that was unaltered by
NETO2. Peak Popen was estimated in patches containing three to five chan-
nels by dividing the peak ensemble current by the weighted mean single-
channel current determined from measurements of the amplitude and
frequency of subconductance levels (Table 1).
Whole-Cell Recordings from Rat Hippocampal Neurons
Dissociated hippocampal cells were prepared from E20 rats as described
(Tomita et al., 2003). Neurons were transfected by calcium phosphate trans-
fection at DIV 7 and whole-cell recordings were made from DIV 12–14 neurons
at 100 mV and room temperature with an EPC-9 amplifier (HEKA). The solu-
tions and recording conditions were the same as those used for the outside-
out patch recordings. Cultures were incubated in concanavalin A (50 mM) for
20 min prior to recording and control and agonist-containing solutions were
applied from thin glass pipettes positioned near the cells.
Synaptic Currents in Transfected Cerebellar Granule Cells
Stargazermice were obtained from Jackson Laboratory and maintained at the
Yale animal facility under the guidelines of the Institutional Animal Care and
Use Committee. Heterozygous male and female mice were mated to obtain
homozygous stargazer mice. Cerebellar granule cell cultures were prepared
from postnatal day 7–9 (P7–9) homozygous stargazer mice and were trans-
fected at DIV 5 as described (Cho et al., 2007). Patch-clamp recordings
from cerebellar granule cells (DIV 7–10) were made in external solution con-
taining (in mM) 10 HEPES, 140 NaCl, 2.5 KCl, 2.5 CaCl2, 1.3 MgSO4,
2.7 MgCl2, and 10 glucose. The frequency of mEPSCs was increased by
making local applications of barium (5 mM) or sucrose (200 mM). Barium
was applied for 250ms three to six times at 10 s intervals. Sucrose was applied
for 2.5 s, also at 10 s intervals. After five cycles of this sucrose protocol, the cell
was locally superfused with normal external solution for 5 min. Release
occurred both during the sucrose application and the wash. Patch pipettes
were filled with recording solution (pH 7.2, 320 mOsm) that contained (in
mM) 130 cesium methanesulfonate, 5 HEPES, 5 Mg-ATP, 0.2 Na-GTP, 20
TEA, and 5 EGTA. All recordings were performed at room temperature. To
Neuron
Identification of a Kainate Receptor Subunitisolate and record kainate-receptor-mediated mEPSCs, tetrodotoxin (1 mM),
AP-5 (100 mM), and picrotoxin (50 mM) were added to the external solution.
mEPSCs were recorded from cerebellar granule cells in whole-cell configura-
tion at a holding potential of70 mV. The current was analog low-pass filtered
at 3 kHz and digitally sampled at 25 kHz.
SUPPLEMENTAL DATA
The supplemental data for this article include 11 Supplemental Figures and
1 Supplemental Table and can be found at http://www.neuron.org/
supplemental/S0896-6273(08)01085-4.
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